The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s small molecule active pharmaceutical ingredient market report forecasts the small molecule active pharmaceutical ingredient market size to grow to $241.11 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Small Molecule Active Pharmaceutical Ingredient Market Report 2023 – https://www.thebusinessresearchcompany.com/report/small-molecule-active-pharmaceutical-ingredient-global-market-report

Small Molecule Active Pharmaceutical Ingredient Market Size Forecast
The global small molecule active pharmaceutical ingredient market is expected to grow from $167.59 billion in 2022 to $180.76 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The small molecule active pharmaceutical ingredient market size is expected to grow to $241.11 billion in 2027 at a CAGR of 7.5%.

North America held the largest small molecule active pharmaceutical ingredient market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Small Molecule Active Pharmaceutical Ingredient Market Driver ­– Increase In The Prevalence Of Diseases
For instance, according to the data from the World Health Organization (WHO), a body of the United Nations responsible for international public health, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. And, in 2020, the bulk of the approximately 422 million individuals with diabetes globally will reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually. Cardiovascular diseases have resulted in the deaths of 17.9 million people worldwide. Therefore, the increasing prevalence of diseases will continue to be the key driver in the small molecule API market.

Request for A Sample Of The Global Small Molecule Active Pharmaceutical Ingredient Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7948&type=smp

Key Small Molecule Active Pharmaceutical Ingredient Market Trend – Strategic Partnerships And Collaborations
Key players operating in the small molecule active pharmaceutical ingredient sector are focused on partnerships and collaborations to reinforce their positions. For instance, in May 2022, NovAliX, a France-based drug discovery company; Alysophil, a France-based company creating new industrial chemistry based on continuous flow chemistry; De Dietrich Process Systems, a France-based provider of solutions for the fine chemical and pharmaceutical industries; and Bruker, a US-based manufacturer of scientific instruments for molecular and materials research, collaborated. Through this partnership, the companies aim to jointly develop a new approach to active pharmaceutical ingredient (API) production and offer complete, standalone, and location-independent API manufacturing solutions to pharmaceutical companies or contract manufacturing organisations (CMOs).

Small Molecule Active Pharmaceutical Ingredient Market Segment
1) By Type: Synthetic, Chemical, or Biological
2) By Therapeutic Type: Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology
3) By Manufacturing Method: In-House, Contract
4) By Application: Clinical, Commercial

Small Molecule Active Pharmaceutical Ingredient Market Major Players and Strategies
Major players in the small molecule active pharmaceutical ingredient market are Albemarle Corporation, Aurobindo Pharma Limited, Dr Reddy’s Laboratories Limited, GSK plc, Merck KGaA, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Johnson Matthey, Gilead Sciences Inc., Allergan Plc, Cambrex Corporation, Siegfried Holding AG, BASF SE, Sanofi SA, Albany Molecular Research Inc., AstraZeneca Plc, and Hoffmann-La Roche Limited.

In March 2021, Piramal Pharma, an India-based pharmaceutical company, acquired Hemmo Pharmaceuticals for a deal amount of $7.75 billion (775 crores). Through this acquisition, Piramal Pharma aims to gain access to the growing peptide active pharmaceutical ingredients (API) market. Hemmo pharmaceutical is an India-based manufacturer that produces peptide products and custom peptide synthesis.

The Small Molecule Active Pharmaceutical Ingredient Global Market Report 2023 covers regional data on small molecule active pharmaceutical ingredient market size, small molecule active pharmaceutical ingredient market trends and drivers, opportunities, strategies, and small molecule active pharmaceutical ingredient market competitor analysis. The countries covered in the small molecule active pharmaceutical ingredient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A small-molecule active pharmaceutical ingredient (API) is any substance or mixture of organic substances or compounds with a low molecular weight intended to be used as the active ingredient in the manufacture of a drug or medicinal product. A small molecule active pharmaceutical ingredient (API) is used as raw materials in the manufacturing of pharmaceutical drugs.

View More Reports Related To The Small Molecule Active Pharmaceutical Ingredient Market –
Pharmaceutical API Manufacturing Global Market Report 2023
Small Electrical Appliance Global Market Report 2023
Pharmaceutical Excipients Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: